To present current evidence regarding differences in presentation, progression, and outcomes between sporadic and familial CCM. We hope this will aid in the guidance and practice of care for CCM patients.

Cerebral Cavernous Malformations (CCMs) are abnormal brain blood vessels clusters, classified as familial (multiple lesions, inherited) or sporadic (single lesions, no family history). Comparing these types is important to define clinical action, genetics, and focus research on new nonsurgical interventions.

 A narrative review was conducted based on recent clinical series and cohort studies (2020-2025) retrieved through PubMed and Google Scholar using the terms “cerebral cavernous malformations,” “sporadic or familial,” “clinical outcomes,” and “hemorrhage.” Eligible studies compared clinical features, radiographic progression, or outcomes. Case reports and exclusively molecular studies were excluded.

Jaman et al. (2023) found familial CCMs (27% of 131 pediatric patients) had larger lesions and faster progression (50% vs 15% sporadic), though symptoms overlapped. Galvão et al. (2024) followed 47 familial patients for 20 years, reporting a 17% hemorrhage rate (1.02%/patient-year) and frequent seizure recurrence, though 91% remained minimally disabled, suggesting multiple lesions does not always predict poor outcomes. Dogu et al. (2025) highlighted heterogeneity with asymptomatic carriers and highly symptomatic relatives; surgery achieved seizure freedom in refractory cases. Fleming et al. (2024) found familial CCM in 19.7% of 315 patients, with longer time to hemorrhage (7.6 vs  2.2 years sporadic). Collectively, familial CCMs appear more aggressive on scans, particularly in children, but many adults remain stable. Sporadic lesions, though often solitary and surgically removable, may carry earlier hemorrhage risk when linked to atypical veins.